NCT00677469View on ClinicalTrials.gov

Low Doses of Cholestyramine in the Treatment of Hyperthyroidism

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Graves Disease
Interventions
DRUG

Cholestyramine

2 grams BID

DRUG

Cholestyramine

1 gram BID

DRUG

Placebo powder

1 gram BID

Trial Locations (1)

Unknown

Endocrine and Metabolism Research Center, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT00677469 - Low Doses of Cholestyramine in the Treatment of Hyperthyroidism | Biotech Hunter | Biotech Hunter